US5071839A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Safe pharmaceutical composition for decreasing side effects of antiviral drugs and increasing the immune function (SDI) II
Assignee: Individual
•
Filing: 1987-11-02
•
Granted: 1991-12-10
•
Expires: 2007-11-02
Abstract
Abstract The new safe pharmaceutical composition (SDI II) and processes are provided for decreasing side effects of antiviral drugs and increasing the immune function. The pharmaceutical composition is composed of two ingredients: Polysaccharides of Wang Qi and Ginsenoside. The SDI II is nontoxic.
Inventors
- 👤 Yaguang Liu
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 05:16
CPC Classifications
A; A61; A61K; A61K36/00; A61K36/18; A61K36/185; A61K36/25; A61K36/258; A61K31/00; A61K31/70; A61K31/7028; A61K31/7034; A61K31/704; A61K31/715; A61K36/48; A61K36/481
Claims Analysis
Total Claims: 3
Claim 1
Independent Claim
61 words
A pharmaceutical composition for decreasing side effects of anti-viral drugs comprising: 20-80 wt. % of polysaccharide of Wang Qi derived from a plant selected from the group consisting of Astragalus membranceus Bge, and Astragalus chrysopterus Bge; and 20-80 wt. % of ginsenoside derived from a plant selected from the group consisting of Panax quinquefolium L and Panax ginseng C. A. Mey.
Claim 2
Dependent Claim
61 words
A pharmaceutical composition for decreasing side effects of anti-viral drugs comprising: 20-80 wt. % of polysaccharide of Wang Qi derived from a plant selected from the group consisting of Astragalus membranceus Bge, and Astragalus chrysopterus Bge; and 20-80 wt. % of ginsenoside derived from a plant selected from the group consisting of Panax quinquefolium L and Panax ginseng C. A. Mey.
Claim 3
Dependent Claim
28 words
A method of reducing side effects of anti-viral drugs in humans suffering thereof comprising: administering to said humans an effective dosage of the pharmaceutical composition of claim 1.
References Cited (Backward Citations)
US4684628A
Cited
US4675318A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-12-09 | 1995-06-10 | 1995-12-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-12-09 | 1999-06-10 | 1999-12-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-12-09 | 2003-06-10 | 2003-12-10 | $7700.00 | Window Closed / Lapsed |